Saxenda is specifically approved for weight management in individuals with obesity or those with a BMI of 27+ who have obesity-related conditions (e.g., high blood pressure, type 2 diabetes)
Top Benefits: Supports sustainable weight management with average losses of up to 15-17% of total body weight in clinical studies Enhances satiety and portion control Promotes balanced blood sugar and metabolic health Dual-agonist injection that activates both GLP-1 and GIP receptors for enhanced appetite regulation, glucose balance, and fat metabolism
Table of Contents Why Breakfast Matters More on GLP-1s Let's get one thing straight: breakfast on GLP-1 medications is a completely different game than regular breakfast
Some patients also ask about compounded versions
Do you always need a Letter of Medical Necessity to buy semaglutide with your HSA/FSA
One of the most common reasons patients discontinue GLP-1 RA treatment is due to gastrointestinal side effects, which could be attributed to the markedly high GLP-1 RA levels
.webp)
